Knights of Columbus Asset Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Knights of Columbus Asset Advisors's GILD Position: Q2 2026 in Review
Knights of Columbus Asset Advisors increased its Gilead Sciences (GILD) stake by 83% in Q2 2026, buying an estimated $6.56M and bringing the position to 109,712 shares worth $13.9M. The position accounts for 0.69% of the portfolio, ranked #32.
Knights of Columbus Asset Advisors first reported a position in GILD in Q1 2017 and has held it in 23 quarters since. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Knights of Columbus Asset Advisors held 109,712 shares of Gilead Sciences worth $13.9M as of Q2 2026.
- Knights of Columbus Asset Advisors bought 49,799 Gilead Sciences shares in Q2 2026, an estimated $6.56M.
- Gilead Sciences made up 0.69% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #32 holding.
- Knights of Columbus Asset Advisors first reported a position in Gilead Sciences in Q1 2017 and has held it in 23 quarters since.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.